Press-release for stocks in the transportation and warehousing sector for skye bioscience, inc.

Prices are updated after-hours

sector : Transportation and warehousing entities : Skye bioscience, inc.

save search

Skye Bioscience Uplists to The Nasdaq Global Market
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 77.21% | O: 6.87% H: 44.87% C: 30.71%
nasdaq bioscience global market

Alpha Star Acquisition Issues Non-Reliance Alert on Annual Reports
Published: 2024-03-28 (Crawled : 14:30) - spacfeed.com
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 13.32% | O: 0.0% H: 9.8% C: 9.07%
acquisition alert star

GCT Semiconductor Shares Up Sixfold After SPAC Deal – MarketWatch
Published: 2024-03-27 (Crawled : 22:00) - spacfeed.com
SOWG P | $16.22 -7.91% 6.6K

Mining, Quarrying, and Oil and ...

| 70.74% | O: 1.05% H: 5.63% C: 4.69%
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 18.01% | O: -0.15% H: 4.29% C: 4.29%
spac semiconductor deal

Drinks With The Deal: Sidley's DuClos on SPACs – Sidley Austin LLP
Published: 2024-03-27 (Crawled : 22:00) - spacfeed.com
SOWG P | $16.22 -7.91% 6.6K

Mining, Quarrying, and Oil and ...

| 61.39% | O: 0.0% H: 4.48% C: 4.48%
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 13.32% | O: 0.0% H: 9.8% C: 9.07%

Skye Bioscience Announces $40 Million Private Placement Equity Financing
Published: 2024-03-11 (Crawled : 19:00) - biospace.com/
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 21.95% | O: -1.31% H: 2.28% C: -23.95%
million bioscience

Skye Bioscience Appoints Dr. Annalisa Jenkins to Board of Directors
Published: 2024-03-04 (Crawled : 12:00) - globenewswire.com
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| -2.87% | O: 1.91% H: 13.84% C: 5.57%
bioscience

Skye Bioscience Completes Enrollment of Phase 2a Clinical Trial of SBI-100 Ophthalmic Emulsion in Glaucoma and Ocular Hypertension
Published: 2024-02-26 (Crawled : 12:00) - globenewswire.com
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 125.69% | O: 6.66% H: 7.43% C: 6.72%
sbi-100 glaucoma ocular bioscience hypertension trial

Skye Bioscience to Present at Oppenheimer Investor Conference
Published: 2024-02-07 (Crawled : 21:00) - biospace.com/
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 206.6% | O: -0.94% H: 4.57% C: -6.67%
conference bioscience

Skye Bioscience Announces $50.25 Million Private Placement Equity Financing
Published: 2024-01-29 (Crawled : 23:00) - biospace.com/
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 598.92% | O: 2.37% H: 26.89% C: 26.05%
million bioscience

Skye Bioscience Receives IND Clearance for Phase 2 Clinical Trial of Nimacimab in Obesity and Chronic Kidney Disease
Published: 2024-01-09 (Crawled : 16:00) - biospace.com/
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 571.49% | O: -7.02% H: 29.11% C: 15.56%
SNY | News | $46.125 0.71% 0.7% 3.7M

Health Technology

| -10.98% | O: 0.74% H: 0.0% C: 0.0%
obesity disease kidney bioscience clearance trial

Skye Bioscience Responds to OTC Markets Promotional Policy
Published: 2023-12-11 (Crawled : 16:00) - biospace.com/
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 364.29% | O: 10.0% H: 15.58% C: 3.9%
bioscience

Skye Announces Clinical Development Plan in Obesity for Differentiated Peripheral CB1 Inhibitor, Nimacimab
Published: 2023-12-11 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K

Health Technology

| -1.16% | O: 0.5% H: 1.67% C: 0.1%
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 364.29% | O: 10.0% H: 15.58% C: 3.9%
SNY | News | $46.125 0.71% 0.7% 3.7M

Health Technology

| -0.74% | O: 2.15% H: 0.0% C: 0.0%
obesity

Skye Bioscience and Tautomer Bioscience Enter Exclusive License for SBI-100 for Development and Sale of Products for Chronic Pain and Other Indications in South Africa and Rest of Africa
Published: 2023-12-05 (Crawled : 17:00) - biospace.com/
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 812.92% | O: 37.64% H: 21.63% C: 15.92%
sbi-100 license bioscience africa

Skye Bioscience Treats First Patient in Glaucoma Phase 2 Study of SBI-100 Ophthalmic Emulsion
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 948.39% | O: 3.23% H: 6.25% C: -3.13%
sbi-100 glaucoma bioscience study phase 2

Skye Bioscience to Present at BTIG Ophthalmology Day and OIS XIII Ophthalmology Innovation Summit
Published: 2023-11-21 (Crawled : 14:30) - biospace.com/
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 860.12% | O: 1.03% H: 0.0% C: -5.85%
day innovation bioscience

Skye Bioscience Announces Positive Phase 1 Trial Results for SBI-100 Ophthalmic Emulsion, Its First-in-Class CB1 Agonist Being Developed for the Treatment of Glaucoma
Published: 2023-10-25 (Crawled : 14:00) - biospace.com/
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 574.27% | O: -0.31% H: 0.0% C: -23.0%
sbi-100 glaucoma agonist positive bioscience treatment trial results

Skye Bioscience to Host Virtual Investor Day on October 25, 2023: "CB1 Axis: Unlocking the Pharmaceutical Potential of the Endocannabinoid System"
Published: 2023-10-20 (Crawled : 21:00) - biospace.com/
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| 524.04% | O: -2.07% H: 1.96% C: 1.96%
day bioscience endocannabinoid potential

Skye Bioscience Receives Clinical Site Approvals for Glaucoma Phase 2a Trial
Published: 2023-09-27 (Crawled : 15:30) - biospace.com/
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| Email alert Add to watchlist
glaucoma bioscience trial

Skye Bioscience Announces Participation at Upcoming Investor Conferences
Published: 2023-09-22 (Crawled : 20:00) - biospace.com/
SKYE | $9.17 -20.98% 27K

Transportation and Warehousing

| Email alert Add to watchlist
bioscience